Pfizer Financial Statements From 2010 to 2020

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:3em;padding-top: 38px;;'>PFE</div>
PFE -- USA Stock  

Trending

Pfizer financial statements provide useful quartarly and yearly information to potential investors in Pfizer Inc about the current and past financial position of the company, as well as its overall management performance and changes in basic fundamentals over time. There are over one hundred sixteen available trending fundamental ratios for Pfizer Inc which can be analyzed over time and compared to other ratios. Please make sure you to check out all of Pfizer Inc recent performance against the performance from 2010 to 2020 to make sure the company is sustainable down the road. Pfizer Average Equity is expected to decrease significantly based on the last few years of reporting. The past year's Average Equity was at 61.66 Billion. The current year Enterprise Value is expected to grow to about 274 B, whereas Average Assets are expected to decline to about 158.5 B.

Search Fundamental Trends

 
Refresh
Check Pfizer financial statements over time to gain insight into the future company performance. Apply historical fundamental analysis to find patterns among financial statement drivers such as Direct Expenses of 12.1 B, Consolidated Income of 15.7 B or Cost of Revenue of 9.9 B, as well as many exotic indicators such as Interest Coverage of 9.09, Long Term Debt to Equity of 0.49 or Calculated Tax Rate of 9.52. This can be a perfect complement to check Pfizer Valuation or Volatility. It can also complement various Pfizer Technical models. Please check the analysis of Pfizer Correlation with competitors.

  Pfizer Revenues

Pfizer Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets189.4 B167.5 B176.1 B
Decreasing
Slightly volatile
Cash and Equivalents1.3 B1.3 BB
Decreasing
Slightly volatile
Investments29.4 B28.7 B33.4 B
Decreasing
Slightly volatile
Investments Current8.7 B8.5 B20.2 B
Decreasing
Slightly volatile
Investments Non Current21.7 B20.1 B13.3 B
Increasing
Very volatile
Property Plant and Equipment Net13.6 B14 B14.4 B
Decreasing
Slightly volatile
Inventory7.5 B8.3 B7.5 B
Decreasing
Stable
Tax Assets6.1 B5.4 BB
Decreasing
Slightly volatile
Trade and Non Trade Receivables8.8 B8.7 B9.7 B
Decreasing
Slightly volatile
Trade and Non Trade Payables4.5 B4.2 BB
Increasing
Slightly volatile
Goodwill and Intangible Assets89.2 B94 B93.3 B
Decreasing
Very volatile
Total Liabilities114.4 B104.3 B103.8 B
Increasing
Stable
Shareholders Equity75 B63.1 B72.4 B
Decreasing
Slightly volatile
Accumulated Retained Earnings Deficit90.4 B97.7 B71.8 B
Increasing
Slightly volatile
Accumulated Other Comprehensive Income(11.9 B)(11.6 B)(7.7 B)
Decreasing
Slightly volatile
Current Assets46.2 B32.8 B49.7 B
Decreasing
Slightly volatile
Assets Non Current124.2 B134.7 B125.7 B
Decreasing
Stable
Current Liabilities31.9 B37.3 B29.3 B
Increasing
Slightly volatile
Liabilities Non Current66.3 B66.7 B73 B
Decreasing
Slightly volatile
Tax Liabilities21.5 B18.7 B27.3 B
Decreasing
Slightly volatile
Total Debt51.7 B52.1 B42.6 B
Increasing
Slightly volatile
Debt Current13.2 B16.2 B8.7 B
Increasing
Slightly volatile
Debt Non Current33.2 B36 B33.4 B
Decreasing
Stable
Shareholders Equity USD64.3 B63.1 B71.6 B
Decreasing
Slightly volatile
Cash and Equivalents USD1.9 B1.3 BB
Decreasing
Slightly volatile
Total Debt USD51.7 B52.1 B42.6 B
Increasing
Slightly volatile
Accounts Payable3.9 B4.2 BB
Increasing
Slightly volatile
Receivables10.4 B8.7 B10 B
Decreasing
Slightly volatile
Inventories7.4 B8.3 B7.3 B
Increasing
Very volatile

Pfizer Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues59.4 B51.8 B55.9 B
Decreasing
Slightly volatile
Cost of Revenue9.9 B10.2 B10.4 B
Increasing
Stable
Selling General and Administrative Expense14 B14.3 B14.8 B
Decreasing
Slightly volatile
Research and Development Expense7.9 B8.7 B7.9 B
Increasing
Stable
Operating Expenses30.2 B31.9 B30.8 B
Decreasing
Stable
Income Tax Expense1.2 B1.4 B1.2 B
Decreasing
Slightly volatile
Net Loss Income from Discontinued Operations(4.3 M)(4 M)(1.7 B)
Increasing
Slightly volatile
Consolidated Income15.7 B16.3 B13 B
Increasing
Stable
Net Income to Non Controlling Interests35.1 M29 M34.6 M
Increasing
Stable
Net Income13.9 B16.3 B12.8 B
Increasing
Stable
Net Income Common Stock15.7 B16.3 B13 B
Increasing
Stable
Weighted Average Shares6.8 B5.6 B6.6 B
Decreasing
Slightly volatile
Weighted Average Shares Diluted6.9 B5.7 B6.7 B
Decreasing
Slightly volatile
Earning Before Interest and Taxes EBIT17.1 B17.7 B14.2 B
Increasing
Very volatile
Revenues USD49.9 B51.8 B52.3 B
Decreasing
Stable
Net Income Common Stock USD15.7 B16.3 B13 B
Increasing
Stable
Earning Before Interest and Taxes USD17.1 B17.7 B14.2 B
Increasing
Very volatile
Gross Profit39.9 B41.5 B41.9 B
Decreasing
Slightly volatile
Operating Income12.4 B10.3 B12 B
Decreasing
Stable
Direct Expenses12.1 B10.2 B11.7 B
Decreasing
Slightly volatile

Pfizer Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(2.8 B)(2.6 B)(1.9 B)
Decreasing
Slightly volatile
Net Cash Flow Business Acquisitions and Disposals(13.5 B)(12.5 B)(9.6 B)
Increasing
Very volatile
Net Cash Flow Investment Acquisitions and Disposals10 B9.3 B4.6 B
Increasing
Stable
Net Cash Flow from Financing(9.2 B)(8.5 B)(13 B)
Increasing
Stable
Issuance Repayment of Debt Securities 9.5 B8.8 B3.6 B
Decreasing
Very volatile
Issuance Purchase of Equity Shares(9.1 B)(8.5 B)(7.1 B)
Decreasing
Stable
Payment of Dividends and Other Cash Distributions (8.7 B)(8 B)(7.1 B)
Decreasing
Slightly volatile
Net Cash Flow from Investing(4.3 B)(3.9 B)(2.5 B)
Decreasing
Stable
Net Cash Flow from Operations15.8 B12.6 B15.9 B
Decreasing
Stable
Effect of Exchange Rate Changes on Cash (34.5 M)(32 M)(132.9 M)
Decreasing
Very volatile
Net Cash Flow or Change in Cash and Cash Equivalents134.9 M125 M(41.7 M)
Decreasing
Very volatile
Share Based Compensation726.8 M718 M632 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion5.9 BB6.3 B
Decreasing
Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share2.362.922.0003
Increasing
Slightly volatile
Earnings per Diluted Share2.332.871.9733
Increasing
Slightly volatile
Earnings per Basic Share USD2.642.922.0433
Increasing
Slightly volatile
Dividends per Basic Common Share1.371.441.1135
Increasing
Slightly volatile
Return on Average Equity20.9425.717917.8933
Increasing
Slightly volatile
Return on Average Assets8.289.95567.3171
Increasing
Slightly volatile
Return on Invested Capital0.20.210.1553
Increasing
Slightly volatile
Gross Margin75.5580.253178.8069
Decreasing
Very volatile
Profit Margin26.3831.445423.6242
Increasing
Stable
EBITDA Margin37.7445.681233.0158
Increasing
Slightly volatile
Return on Sales0.330.3410.2699
Increasing
Very volatile
Asset Turnover0.350.31660.3156
Increasing
Very volatile
Payout Ratio0.630.4930.6315
Increasing
Very volatile
Enterprise Value over EBITDA13.0211.26912.4931
Increasing
Slightly volatile
Enterprise Value over EBIT18.7915.018.799
Increasing
Slightly volatile
Price to Earnings Ratio17.3413.41817.7796
Increasing
Stable
Sales per Share8.439.29258.4164
Increasing
Slightly volatile
Price to Sales Ratio4.324.2163.8234
Increasing
Slightly volatile
Price to Book Value3.373.4342.862
Increasing
Slightly volatile
Debt to Equity Ratio0.680.82590.5917
Increasing
Slightly volatile
Dividend Yield0.03460.0370.0354
Decreasing
Slightly volatile
Current Ratio0.90.87931.7124
Decreasing
Slightly volatile
Free Cash Flow per Share1.91.86962.1455
Increasing
Stable
Book Value per Share10.6411.33811.0626
Decreasing
Stable
Tangible Assets Book Value per Share12.2413.19212.6384
Decreasing
Slightly volatile
Total Assets Per Share27.3330.265527.1002
Increasing
Slightly volatile
Cash Flow Per Share2.242.27472.4466
Increasing
Stable
Return on Investment11.029.378510.553
Increasing
Very volatile
Operating Margin19.7219.974921.6668
Decreasing
Very volatile
Calculated Tax Rate9.527.82729.3589
Decreasing
Slightly volatile
Receivables Turnover5.596.17955.5622
Increasing
Slightly volatile
Inventory Turnover1.591.29431.5594
Decreasing
Slightly volatile
PPandE Turnover3.593.7843.7788
Increasing
Stable
Cash and Equivalents Turnover45.6942.348625.9607
Increasing
Slightly volatile
Accounts Payable Turnover14.111.637113.8077
Decreasing
Slightly volatile
Accrued Expenses Turnover13.9911.167514.0146
Decreasing
Slightly volatile
Interest Coverage9.097.668411.7369
Decreasing
Very volatile
Long Term Debt to Equity0.490.56940.4647
Increasing
Slightly volatile
Quick Ratio0.510.49741.1861
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets(2.7581)(2.6873)10.4971
Decreasing
Slightly volatile
Revenue to Assets0.350.3090.3195
Decreasing
Stable

Pfizer Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share2.362.922.0003
Increasing
Slightly volatile
Earnings per Diluted Share2.332.871.9733
Increasing
Slightly volatile
Earnings before Tax17.1 B17.7 B14.2 B
Increasing
Very volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA20 B23.6 B18.1 B
Increasing
Stable
Earnings per Basic Share USD2.642.922.0433
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD20.9 B23.7 B20.2 B
Decreasing
Very volatile
Dividends per Basic Common Share1.371.441.1135
Increasing
Slightly volatile
Market Capitalization225.4 B216.8 B199.9 B
Increasing
Slightly volatile
Enterprise Value274 B266.7 B239.1 B
Increasing
Slightly volatile
Invested Capital84.8 B87 B90.7 B
Decreasing
Slightly volatile
Average Equity63.2 B61.7 B70.7 B
Decreasing
Slightly volatile
Average Assets158.5 B162.4 B170.3 B
Decreasing
Slightly volatile
Invested Capital Average83.6 B84.3 B91.2 B
Decreasing
Slightly volatile
Tangible Asset Value73.9 B73.5 B81.9 B
Decreasing
Slightly volatile
Return on Average Equity20.9425.717917.8933
Increasing
Slightly volatile
Return on Average Assets8.289.95567.3171
Increasing
Slightly volatile
Free Cash Flow11.2 B10 B14.3 B
Decreasing
Slightly volatile
Return on Invested Capital0.20.210.1553
Increasing
Slightly volatile
Gross Margin75.5580.253178.8069
Decreasing
Very volatile
Profit Margin26.3831.445423.6242
Increasing
Stable
EBITDA Margin37.7445.681233.0158
Increasing
Slightly volatile
Return on Sales0.330.3410.2699
Increasing
Very volatile
Asset Turnover0.350.31660.3156
Increasing
Very volatile
Payout Ratio0.630.4930.6315
Increasing
Very volatile
Enterprise Value over EBITDA13.0211.26912.4931
Increasing
Slightly volatile
Enterprise Value over EBIT18.7915.018.799
Increasing
Slightly volatile
Price to Earnings Ratio17.3413.41817.7796
Increasing
Stable
Sales per Share8.439.29258.4164
Increasing
Slightly volatile
Price to Sales Ratio4.324.2163.8234
Increasing
Slightly volatile
Price to Book Value3.373.4342.862
Increasing
Slightly volatile
Debt to Equity Ratio0.680.82590.5917
Increasing
Slightly volatile
Dividend Yield0.03460.0370.0354
Decreasing
Slightly volatile
Current Ratio0.90.87931.7124
Decreasing
Slightly volatile
Working Capital(4.6 B)(4.5 B)18.3 B
Decreasing
Slightly volatile
Free Cash Flow per Share1.91.86962.1455
Increasing
Stable
Book Value per Share10.6411.33811.0626
Decreasing
Stable
Tangible Assets Book Value per Share12.2413.19212.6384
Decreasing
Slightly volatile
Total Assets Per Share27.3330.265527.1002
Increasing
Slightly volatile
Cash Flow Per Share2.242.27472.4466
Increasing
Stable
Revenue Per Employee655.7 K586.1 K604.9 K
Decreasing
Stable
Net Income Per Employee156.6 K184.3 K143 K
Increasing
Stable
Return on Investment11.029.378510.553
Increasing
Very volatile
Operating Margin19.7219.974921.6668
Decreasing
Very volatile
Calculated Tax Rate9.527.82729.3589
Decreasing
Slightly volatile
Receivables Turnover5.596.17955.5622
Increasing
Slightly volatile
Inventory Turnover1.591.29431.5594
Decreasing
Slightly volatile
PPandE Turnover3.593.7843.7788
Increasing
Stable
Cash and Equivalents Turnover45.6942.348625.9607
Increasing
Slightly volatile
Accounts Payable Turnover14.111.637113.8077
Decreasing
Slightly volatile
Accrued Expenses Turnover13.9911.167514.0146
Decreasing
Slightly volatile
Interest Coverage9.097.668411.7369
Decreasing
Very volatile
Long Term Debt to Equity0.490.56940.4647
Increasing
Slightly volatile
Quick Ratio0.510.49741.1861
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets(2.7581)(2.6873)10.4971
Decreasing
Slightly volatile
Revenue to Assets0.350.3090.3195
Decreasing
Stable

Pfizer Fundamental Market Drivers

Short Percent Of Float0.97%
Forward Price Earnings10.79
Shares Short Prior Month52.59M
Average Daily Volume Last 10 Day33.17M
Average Daily Volume In Three Month28.12M
Date Short Interest15th of June 2020
Fifty Day Average34.84
Two Hundred Day Average35.95

Pfizer Upcoming Events

Upcoming Quarterly Report28th of July 2020
Next Earnings Report3rd of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End26th of January 2021
Last Quarter Report31st of March 2020
Last Earning Announcement30th of June 2019

About Pfizer Financial Statement Charts

There are typically three primary documents that fall into the category of financial statements. These documents include Pfizer income statement, its balance sheet, and the statement of cash flows. Pfizer investors use historical funamental indicators, such as Pfizer's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pfizer investors may use each financial statement separately, they are all related. The changes in Pfizer's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pfizer's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pfizer Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pfizer. Please read more on our technical analysis and fundamental analysis pages.
 2017 2018 2019 2020 (projected)
Receivables8.22 B8.03 B8.72 B10.38 B
Inventories7.58 B7.51 B8.28 B7.42 B

Current Sentiment - PFE

Pfizer Inc Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Pfizer Inc. What is your perspective on investing in Pfizer Inc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

S   
Sold over 300 shares of
few days ago
Traded for 8.62
GM   
Sold over 100 shares of
few days ago
Traded for 25.24
XOM   
Sold over 60 shares of
few days ago
Traded for 44.08
OTPBF   
Sold over 100 shares of
few days ago
Traded for 28.82
MSFT   
Sold few shares of
few days ago
Traded for 206.26
Please check the analysis of Pfizer Correlation with competitors. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page